- Poster presentation
- Open access
- Published:
Interim sample size re-estimation in the IIVOP trial
Trials volume 16, Article number: P128 (2015)
The IIVOP trial is a cross-over trial which examines the effect of the drug ivabridine in reducing pain in an enriched healthy volunteer pain model. The trial was designed based on very limited information, and as such an interim analysis was built into the design to allow the re-estimation of the sample size requirements based on updated trial parameters.
The blinded data will be used to assess the assumptions regarding the variability of the primary endpoint. If appropriate and feasible the sample size may be increased to ensure that the study is not under-powered due to incorrect assumptions. In order to control for biases, the trial will not terminate early even if the interim sample size calculations suggests that enough patients have already been enrolled to reach the desired power.
The steps of the interim sample size re-calculation, including decisions made and results, will be presented.
Author information
Authors and Affiliations
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Dawson, S., Lee, M. & Bond, S. Interim sample size re-estimation in the IIVOP trial. Trials 16 (Suppl 2), P128 (2015). https://doi.org/10.1186/1745-6215-16-S2-P128
Published:
DOI: https://doi.org/10.1186/1745-6215-16-S2-P128